Pfizer, a Rs. 1,800 crore plus pharma MNC
after merging Wyeth, has decided to shut down its over 50 years Thane
facility from September 16, 2015. The decision to close the site is
based on an assessment its long term viability and its ability to
achieve the needed production. There has practically been no production
activity at this plant since 2013, and the closure will not impact the
supply of any of our medicines to patients.
The company had offered a generous voluntary retirement scheme (VRS) to the workmen at this site last year, upon their request. This was taken up by as many as 132 of the 212 workmen. The remaining 80 workmen have continued to receive full wages, despite plant inactivity. As a part of the closure process, the company will honour its obligations towards requisite compensation, as mandated by law, for the remaining workmen. We are grateful for the contribution of the workmen and colleagues and will ensure that they are treated with fairness and respect.
Pfizer remains committed to providing high quality medicines to our patients and customers in India.
The company had offered a generous voluntary retirement scheme (VRS) to the workmen at this site last year, upon their request. This was taken up by as many as 132 of the 212 workmen. The remaining 80 workmen have continued to receive full wages, despite plant inactivity. As a part of the closure process, the company will honour its obligations towards requisite compensation, as mandated by law, for the remaining workmen. We are grateful for the contribution of the workmen and colleagues and will ensure that they are treated with fairness and respect.
Pfizer remains committed to providing high quality medicines to our patients and customers in India.
No comments:
Post a Comment